0001543053-17-000002.txt : 20170831
0001543053-17-000002.hdr.sgml : 20170831
20170831190443
ACCESSION NUMBER: 0001543053-17-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170830
FILED AS OF DATE: 20170831
DATE AS OF CHANGE: 20170831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harrelson Lori R.
CENTRAL INDEX KEY: 0001543053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 171064244
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27704
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-08-30
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001543053
Harrelson Lori R.
4233 TECHNOLOGY DRIVE
DURHAM
NC
27704
0
1
0
0
Vice President of Finance
Common Stock
2017-08-30
4
A
0
320683
0
A
354382
D
The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 160,341 shares on January 2, 2018, and with respect to the remaining 160,342 shares on January 9, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.
/s/ Lori R. Harrelson, attorney-in-fact
2017-08-31